Medicinsk godkendt artikel
Emgality is used as a preventive treatment for migraines.
Emgality has been developed specifically to prevent migraines and is approved for adults who have at least 4 seizures a month.
It is known that CGRP (calcitonin gene-related peptide), which is formed in our nervous system, plays an active role in a migraine attack.
Emgality works by binding specifically to and blocking the activity of the CGRP molecule in the brain. This can decrease the number and strength of your migraine attacks.
Emgality has a half-life of about 27 days.
Reaction around the injection site, skin itching, rash and constipation. Very rarely anaphylactic reaction.
You should not use Emgality if you have certain forms of cardiovascular disease.
Emgality must not be used by pregnant women and breast-feeding mothers.
You must stop taking Emgality at least 5 months before you try to get pregnant.
Checked blood pressure
The first time you take Emgality, you should have a shock dose, i.e. 2 pens of 120 mg each.
Going forward, inject 1 dose of 120 mg once every month (one pen).
We recommend that you take Emgality out of the refrigerator about ½ hour before use.
Do not shake the EmgalityPen.
Emgality can be injected into either the thigh or abdomen. If you have one to help you, it can also be injected into the upper arm.
Check that the liquid in the pen is clear and without precipitate.
When dispensing Emgality, be sure to put it in the refrigerator within 4 hours. Store Emgality in a refrigerator at 2-8°C protected from light. Does not tolerate frost.
Can be stored for up to 7 days at max 30°C. Unused pens must then be discarded.
